Elevated peroxisome proliferator-activated receptor gamma (PPARy) levels in the liver are associated with hepatic steatosis, while hepatocyte specific disruption of PPARy (Pparg) gene expression decreased liver steatosis in ob/ob mice [43,44,45]. The gene discussed is PPARG; the disease is fatty liver disease.